CNH Global N.V. (ADR)

NYSE: CNH
Time for our daily look at the world of commodity prices and key developments. Corn futures continue their seemingly inexorable march toward $8/bushel as wet and windy weather in the US Midwest...
Rising food prices may be hurting consumers around the globe, but they aren’t doing any damage to the farmers who raise the food and the companies that supply those farmers with equipment. Deere &...
The message delivered today by earnings reports from Potash Corp. of Saskatchewan (NYSE: POT), Caterpillar Inc. (NYSE: CAT), and CNH Global N.V. (NYSE: CNH) is that as long as the world’s...
The US Department of Agriculture this morning released its January World Agricultural Supply and Demand Estimates, or WASDE, which projects world supply and demand for food products like wheat, corn,...
Rising commodity prices, especially for agricultural products, are pushing up land prices and stock prices for some of the biggest players in the agricultural sector. Prices for cotton, corn, and...
Recent earnings reports from machinery makers Caterpillar Inc. (NYSE:CAT) and Deere & Co. (NYSE:DE) have been weak, but getting better. Caterpillar reported fourth-quarter and full-year 2009 earnings...
Autodesk Inc. (NASDAQ: ADSK) rallied over 5% to a yearly high of $27.26 after the company’s shares were upgraded to “buy” by Kaufman Brothers LP, who set their 12 month price target...
These are some of the top pre-market analyst downgrades and negative calls from Wall Street we have seen early this Monday morning with more than two and a half hours to the market open: Bank of...
These are the top 10 analyst calls that we are focusing on this Tuesday morning: AGCO Corp. (NYSE: AG) raised to Overweight at Goldman Sachs. HSBC Holdings (NYSE: HBC) cut to Neutral at UBS CNH...
Goldman Sachs is making a change to its CONVICTION BUY LIST this morning.  The firm is adding CIGNA (NYSE: CI) and dropping WellPoint (NYSE: NYSE: WLP) from the list.  Both stocks are still...
We are full fledged into earnings season now, so most news coverage will point to the current earnings environment and guidance.  There are of course drug developments and other contracts...